However, previous data from our lab demonstrated that overexpression of CacyBP/SIP inhibits the growth of renal carcinoma cells and gastric cancer cells, suggesting that CacyBP/SIP has tumor-specific roles, similar to SIRT1, NF-κB, and TGF-beta [36–38]. Here, CACYBP is linked to renal carcinoma.